Skip to main content

Dr John Thomas Lear

Consultant Dermatologist

MB ChB MD FRCCP(UK)

Practices at: BMI The Alexandra Hospital

A photo of Dr John Thomas Lear

Dr John Lear is Consultant Dermatologist at BMI The Alexandra Hospital and his NHS practices, Salford Royal NHS Foundation Trust and Manchester Foundation Trust, where he has worked as a consultant for over 21 years. He sees patients with all problems of the skin, diagnosing and treating them, as well as working with excellent surgical teams to provide a comprehensive service. He has an interest in all aspects of general dermatology including paediatric dermatology and hair disorders. His main specialist interest is the diagnosis and management of skin cancer and pigmented and precancerous lesions. He has a particular interest in the non-surgical management of these conditions, including topical photodynamic therapy (PDT). He set up and ran the PDT service in his NHS practice for the non surgical treatment of superficial skin cancers and precancerous lesions. Dr Lear has an established interest in mole mapping and mole clinics for assessment and treatment of moles, and set up this service in his NHS practice. 

He has a national and international reputation for his work on skin cancer which spans over 25 years. He is rated 6th in the world’s top experts for basal cell carcinoma (BCC, one of the commonest cancers worldwide), second in the world for basal cell naevus syndrome/Gorlin Syndrome (a genetic condition predisposing to hundreds of skin cancers), and 24th in the world for actinic keratosis (a precursor of skin cancer) on expertscape.com (a website objectively ranking the worlds experts based on scientific output).  

He was the Skin Cancer Pathway Lead For Greater Manchester for over 5 years, he set up and chaired the specialist skin cancer multidisciplinary meeting (SSMDT) for Greater Manchester, was appointed National Clinical Lead for the development of Standards of Care For Skin Cancer by NHS England, was deputy chair of the NHS England Clinical expert group for skin cancer, is deputy chair of the NICE Clinical guidelines development group for updating National guidance of malignant melanoma, was a member of the British Association of Dermatologists (BAD) National Basal cell carcinoma guidelines group and their publication, is a Member of the BAD skin cancer and clinical services committee, was a member of the BAD clinical guidelines committee, and he wrote the Skin cancer section of the National curriculum for the training of Dermatologists in the UK. He was a member of the NCRI national skin cancer committee and NCIN national skin cancer data/research committee. 

Having qualified in medicine in 1991 at Leicester University with distinction in medicine, Dr Lear underwent general medical training in Leicester, following which he undertook his dermatological training in the Midlands and the South West as a senior registrar before taking up his present consultant post in 2000. 

Dr Lear has published over 250 research papers, books, book chapters, reviews and abstracts on the genetics, epidemiology, diagnosis and therapy of skin cancer. He has given numerous lectures both nationally and internationally. His work has been cited by other researchers over 9000 times. He has undertaken numerous clinical trials and continues to be involved in research into the latest developments in skin cancer therapy, and has been involved in first in human studies of the latest cutting edge therapies. 

He runs dedicated clinics for skin problems for those with renal transplants and other immunosuppressed groups, both groups who represent a significant challenge in skin cancer management. He also looks after the largest population of Gorlin Syndrome patients in Europe, many of whom have hundreds of skin cancers. He therefore spends much of his working week treating and managing very high risk skin cancer patients and gets referrals from within and outside the region for this. He is a long-standing medical adviser to the UK Gorlin Syndrome Group, a group set up and run by patients/relatives/carers of those affected by this syndrome. He is actively involved in trying to improve the lives of these patients through clinical care, research and attending/speaking at the group’s national conference. 

Dr Lear is a founding member of the British Society for Skin Care in Immunocompromised individuals, (BSSCII), a body committed to promoting excellence in dermatological care in these high risk patients. He is on the working party to develop national follow up guidelines in these patients. 

He is actively involved in teaching and training, both undergraduates, dermatological trainees, GP's and allied professionals. He teaches on numerous courses and meetings for GP's, including annual courses, evening meetings and teach and treat type events. He is involved in interviewing applicants for medical school and for entry into dermatological training.

  • Moles, regular mole checks, mole mapping
  • Skin lesions, Warts, Lumps and Bumps, lipomas, cysts
  • Skin cancer including surgical and non-surgical treatments
  • Photodynamic therapy for precancerous lesions and superficial skin cancers
  • Acne, Eczema, Psoriasis and all rashes
  • Hair loss
  • Itching
  • All aspects of general dermatology
  • Teaching and training
  • Paediatric dermatology

  • Royal College of Physicians
  • British Medical Association
  • British Association of Dermatologists
  • British Society for Dermatological Surgery
  • British society for Skin Care in Immunocompromised Individuals

Ways to pay

credit card

Pay for yourself

Pay for yourself with our fixed price packages. This includes your pre-assessment, treatment, follow-ups and six months of aftercare.

Find out more

insurance

Pay with health insurance

We are widely recognised by health insurers. Ask your insurer about your cover and for an insurer pre-authorisation code.

Find out more

direct debit

Spread the cost

Pay for yourself with monthly repayments spread over 12 months, interest-free (terms and conditions apply)

Find out more

General Enquiries